Literature DB >> 12505290

Diet and prostate cancer.

Tomoyuki Shirai1, Makoto Asamoto, Satoru Takahashi, Katsumi Imaida.   

Abstract

The importance of dietary factors for prostate carcinogenesis has been proven by epidemiological studies of immigrants from Asia into the USA. Intake of foodstuffs rich in fat, including meat, is suggested to be a risk factor. Experimentally, while some studies demonstrated high fat intake to promote rat prostate carcinogenesis, others did not. Charcoal-cooked red meat and fish have been demonstrated to contain heterocyclic amines that are carcinogenic in rodents and non-primates. Among them, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) has been shown to induce cancers in the mammary glands, colon and prostate of rats. Although there are epidemiological data showing that PhIP could contribute to the development of breast cancer, equivalent evidence for prostate cancer is lacking. However, as protective dietary factors, micronutrients such as selenium, zinc, isoflavones, carotenoids and lycopenes and vitamins E and D have been listed. Animal experimentation on prostate cancer has consistently supported preventive potential for carotenoids and isoflavones, in contrast to the inconsistent results with high fat diets. Although the diet has apparently an important influence on prostate carcinogenesis in man, further research is necessary for clarification of specific factors in man.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12505290     DOI: 10.1016/s0300-483x(02)00260-3

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  15 in total

1.  Molecular effects of soy phytoalexin glyceollins in human prostate cancer cells LNCaP.

Authors:  Florastina Payton-Stewart; Norberta W Schoene; Young S Kim; Matthew E Burow; Thomas E Cleveland; Stephen M Boue; Thomas T Y Wang
Journal:  Mol Carcinog       Date:  2009-09       Impact factor: 4.784

2.  The influence of occupational exposure to pesticides, polycyclic aromatic hydrocarbons, diesel exhaust, metal dust, metal fumes, and mineral oil on prostate cancer: a prospective cohort study.

Authors:  D Boers; M P A Zeegers; G M Swaen; Ij Kant; P A van den Brandt
Journal:  Occup Environ Med       Date:  2005-08       Impact factor: 4.402

3.  Characterization of 2-amino-1-methyl-6-phenylimidazo[4,5b]pyridine at androgen receptor: mechanistic support for its role in prostate cancer.

Authors:  Mashunté Glass-Holmes; Byron J Aguilar; Richard D Gragg; Selina Darling-Reed; Carl B Goodman
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

4.  Estrogen receptor alpha and imprinting of the neonatal mouse ventral prostate by estrogen.

Authors:  Yoko Omoto; Otabek Imamov; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

5.  Examining the relationship between obesity and prostate cancer.

Authors:  Stephen J Freedland; William J Aronson
Journal:  Rev Urol       Date:  2004

6.  Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model.

Authors:  Alexander D Borowsky; Karen H Dingley; Esther Ubick; Kenneth W Turteltaub; Robert D Cardiff; Ralph Devere-White
Journal:  Neoplasia       Date:  2006-09       Impact factor: 5.715

7.  Serum prostate-specific antigen levels in older men with or at risk of HIV infection.

Authors:  L E Vianna; Y Lo; R S Klein
Journal:  HIV Med       Date:  2006-10       Impact factor: 3.180

8.  The value of prostate-specific antigen in Asia.

Authors:  Chaidir Arif Mochtar; R Siddhi Andika
Journal:  Ther Adv Urol       Date:  2010-04

9.  Metabolic syndrome in sub-Saharan Africa: "smaller twin" of a region's prostatic diseases?

Authors:  Chukwunonso E C C Ejike; Lawrence U S Ezeanyika
Journal:  Int Urol Nephrol       Date:  2008-02-21       Impact factor: 2.370

10.  Pancreatic cancer mortality in China (1991-2000).

Authors:  Li Wang; Gong-Huan Yang; Xing-Hua Lu; Zheng-Jing Huang; Hui Li
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.